-
公开(公告)号:US08202910B2
公开(公告)日:2012-06-19
申请号:US12255976
申请日:2008-10-22
IPC分类号: A61K31/132 , A61K31/135 , A61K31/44 , A61K31/445
CPC分类号: A61K31/132 , A61K31/13 , A61K31/137 , C07C211/01 , C07C215/06 , Y02A50/401 , Y02A50/402
摘要: Methods and compositions for treating disease caused by infectious agents, particularly tuberculosis. In particular, methods and compositions comprising substituted ethylene diamines for the treatment of infectious diseases are provided. In one embodiment, these methods and compositions are used for the treatment of mycobacterial infections, including, but not limited to, tuberculosis. In certain embodiments, the present invention comprises compositions comprising novel substituted ethylene diamine compounds further comprising antitubercular agents such as rifampicin, isoniazid, pyrazinamide and ethambutol.
摘要翻译: 用于治疗由感染因子,特别是结核病引起的疾病的方法和组合物。 特别地,提供了包含用于治疗感染性疾病的取代的乙二胺的方法和组合物。 在一个实施方案中,这些方法和组合物用于治疗分枝杆菌感染,包括但不限于结核病。 在某些实施方案中,本发明包含还包含抗结核剂如利福平,异烟肼,吡嗪酰胺和乙胺丁醇的新型取代的乙二胺化合物的组合物。